Small molecules, which allow complete control over a genetic defect responsible for muscular dystrophy have been discovered by scientists. These small molecules will enable scientists to investigate potential new therapies and to study the long-term impact of the disease. The Scripps Research Institute (TSRI) Associate Professor Matthew Disney said that this easy approach is an entirely new way to turn a genetic defect off or on. Myotonic ...
via Medindia Health News More READ
No comments:
Post a Comment